Have a feature idea you'd love to see implemented?
Let us know!
EVH Evolent Health Inc
Price (delayed)
$22.41
Market cap
$2.61B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.95
Enterprise value
$3.14B
Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Its solutions encompass total cost of care management, specialty care
Highlights
The revenue has grown by 44% YoY and by 8% from the previous quarter
Evolent Health's net income has increased by 34% QoQ and by 2.2% YoY
The EPS fell by 36% YoY but it rose by 25% QoQ
EVH's gross profit is up by 8% year-on-year but it is down by 2.3% since the previous quarter
The gross margin has contracted by 25% YoY and by 10% from the previous quarter
The company's equity fell by 14% QoQ and by 3.6% YoY
Key stats
What are the main financial stats of EVH
Market
Valuations
Earnings
Shares outstanding
116.29M
Market cap
$2.61B
Enterprise value
$3.14B
Price to earnings (P/E)
N/A
Price to book (P/B)
2.47
Price to sales (P/S)
1.09
EV/EBIT
N/A
EV/EBITDA
44.04
EV/Sales
1.33
Revenue
$2.35B
EBIT
-$50.07M
EBITDA
$71.31M
Free cash flow
$150.93M
Per share
Balance sheet
Liquidity
EPS
-$0.95
Free cash flow per share
$1.32
Book value per share
$9.07
Revenue per share
$20.52
TBVPS
$5.64
Total assets
$2.48B
Total liabilities
$1.24B
Debt
$635.71M
Equity
$1.05B
Working capital
$37.6M
Debt to equity
0.6
Current ratio
1.08
Quick ratio
1.02
Net debt/EBITDA
7.49
Margins
Efficiency
Dividend
EBITDA margin
3%
Gross margin
18.6%
Net margin
-2.9%
Operating margin
-0.8%
Return on assets
-4.1%
Return on equity
-9.6%
Return on invested capital
-7.9%
Return on capital employed
-2.5%
Return on sales
-2.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EVH stock price
How has the Evolent Health stock price performed over time
Intraday
-2.4%
1 week
-15.53%
1 month
-25.25%
1 year
-14.04%
YTD
-32.15%
QTD
-20.76%
Financial performance
How have Evolent Health's revenue and profit performed over time
Revenue
$2.35B
Gross profit
$437.01M
Operating income
-$18.76M
Net income
-$69.03M
Gross margin
18.6%
Net margin
-2.9%
The operating margin has soared by 74% YoY and by 69% from the previous quarter
The company's operating income has surged by 66% QoQ and by 63% YoY
The revenue has grown by 44% YoY and by 8% from the previous quarter
The net margin has increased by 40% QoQ and by 33% YoY
Growth
What is Evolent Health's growth rate over time
Valuation
What is Evolent Health stock price valuation
P/E
N/A
P/B
2.47
P/S
1.09
EV/EBIT
N/A
EV/EBITDA
44.04
EV/Sales
1.33
The EPS fell by 36% YoY but it rose by 25% QoQ
The company's equity fell by 14% QoQ and by 3.6% YoY
EVH's price to book (P/B) is 13% lower than its 5-year quarterly average of 2.9 and 13% lower than its last 4 quarters average of 2.9
The revenue has grown by 44% YoY and by 8% from the previous quarter
The price to sales (P/S) is 41% lower than the 5-year quarterly average of 1.9 and 30% lower than the last 4 quarters average of 1.6
Efficiency
How efficient is Evolent Health business performance
The ROS has soared by 76% YoY and by 42% QoQ
EVH's return on invested capital has surged by 66% year-on-year and by 34% since the previous quarter
The ROE has grown by 24% from the previous quarter but it has contracted by 23% YoY
Evolent Health's return on assets has increased by 23% QoQ but it has decreased by 17% YoY
Dividends
What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EVH.
Financial health
How did Evolent Health financials performed over time
The company's total assets is 100% higher than its total liabilities
The total liabilities has decreased by 13% from the previous quarter and by 10% YoY
The company's current ratio rose by 6% QoQ
The debt is 40% lower than the equity
EVH's debt to equity is up by 15% since the previous quarter but it is down by 6% year-on-year
The company's equity fell by 14% QoQ and by 3.6% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.